Comparative Pharmacology
Head-to-head clinical analysis: TECHNEGAS KIT versus TECHNETIUM TC 99M MEBROFENIN.
Peer-Reviewed Evidence
Head-to-head clinical analysis: TECHNEGAS KIT versus TECHNETIUM TC 99M MEBROFENIN.
TECHNEGAS KIT vs TECHNETIUM TC-99M MEBROFENIN
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Technetium Tc-99m generator that produces pertechnetate ion, which is taken up by thyroid, salivary glands, stomach, and choroid plexus; also used for radiolabeling of other compounds.
Technetium Tc-99m mebrofenin is a radiopharmaceutical that, after intravenous administration, is taken up by hepatocytes and excreted into the biliary system. It allows scintigraphic imaging of the liver and biliary tract by emitting gamma rays detectable by a gamma camera.
Inhalation: 740-1110 MBq (20-30 mCi) of Technetium-99m DTPA aerosol, administered via nebulizer over 3-5 minutes.
Adults: 1-5 mCi (37-185 MBq) IV bolus. Image immediately and at intervals up to 60 minutes for hepatobiliary scintigraphy.
None Documented
None Documented
Clinical Note
moderateTechnetium Tc-99m mebrofenin + Teriflunomide
"The serum concentration of Teriflunomide can be increased when it is combined with Technetium Tc-99m mebrofenin."
Clinical Note
moderateTechnetium Tc-99m mebrofenin + Eltrombopag
"The serum concentration of Eltrombopag can be increased when it is combined with Technetium Tc-99m mebrofenin."
Physical half-life of 99mTc: 6.02 hours; effective half-life after inhalation: approximately 6.02 hours (clearance limited by physical decay, as the agent is inert)
Terminal elimination half-life: approximately 6 hours (range 4-8 hours) in patients with normal hepatic function. In obstructive jaundice, half-life may be prolonged due to delayed biliary excretion.
Renal: 100% as unchanged pertechnetate (99mTcO4-); biliary/fecal: negligible
Primarily biliary (hepatobiliary) excretion: ~75% of administered activity is excreted into bile and subsequently into feces within 24 hours. Renal excretion accounts for <10% of the administered dose.
Category C
Category C
Diagnostic Radiopharmaceutical
Diagnostic Radiopharmaceutical